Relates to adverse determinations related to a step therapy protocol override determination; repealer
It became law on Feb 7, 2024.
- Stage
- Became law
- Sponsor
- 1
- Latest action
- Feb 7, 2024
What it does
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
Where it stands
This bill passed and is now law.
Introduced (Done)
Committee (Done)
Floor (Done)
Law (Done)
What moved
Loading recorded actions…
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
Once a bill is decided, the questions are about what is done with it in New York.